Ophthalmology Flashcards
Glaucoma
Glaucoma refers to the optic nerve damage that is caused by a significant rise in intraocular pressure. The raised intraocular pressure is caused by a blockage in aqueous humour trying to escape the eye. There are two types of glaucoma: open-angle and closed-angle.
Basic anatomy and physiology of the eye
The vitreous chamber of the eye is filled with vitreous humour.
The anterior chamber between the cornea and the iris and the posterior chamber between the lens and the iris are filled with aqueous humour that supplies nutrients to the cornea.
The aqueous humour is produced by the ciliary body. The aqueous humour flows from the ciliary body, around the lens and under the iris, through the anterior chamber, through the trabecular meshwork and into the canal of Schlemm. From the canal of Schlemm it eventually enters the general circulation.
The normal intraocular pressure is 10-21 mmHg. This pressure is created by the resistance to flow through the trabecular meshwork into the canal of Schlemm.
Pathophysiology of open-angle glaucoma
In open-angle glaucoma, there is a gradual increase in resistance through the trabecular meshwork. This makes it more difficult for aqueous humour to flow through the meshwork and exit the eye. Therefore the pressure slowly builds within the eye and this gives a slow and chronic onset of glaucoma.
In acute angle-closure glaucoma, the iris bulges forward and seals off the trabecular meshwork from the anterior chamber preventing aqueous humour from being able to drain away. This leads to a continual build-up of pressure. This is an ophthalmology emergency.
Increased pressure in the eye causes cupping of the optic disc. In the centre of a normal optic disc is the optic cup. This is a small indent in the optic disc. It is usually less than half the size of the optic disc. When there is raised intraocular pressure, this indent becomes larger as the pressure in the eye puts pressure on that indent making it wider and deeper. This is called “cupping”. An optic cup greater than 0.5 the size of the optic disc is abnormal.
Risk factors for open-angle glaucoma
Increasing age
Family history
Black ethnic origin
Nearsightedness (myopia)
Presentation of open-angle glaucoma
Often the rise in intraocular pressure is asymptomatic for a long period of time. It is diagnosed by routine screening when attending optometry for an eye check.
Glaucoma affects peripheral vision first. Gradually the peripheral vision closes in until they experience tunnel vision.
It can present with gradual onset of fluctuating pain, headaches, blurred vision and halos appearing around lights, particularly at night time.
Measuring intraocular pressure
Non-contact tonometry is the commonly used machine for estimating intraocular pressure by opticians. It involves shooting a “puff of air” at the cornea and measuring the corneal response to that air. It is less accurate but gives a helpful estimate for general screening purposes.
Goldmann applanation tonometry is the gold standard way to measure intraocular pressure. This involves a special device mounted on a slip lamp that makes contact with the cornea and applies different pressures to the front of the cornea to get an accurate measurement of what the intraocular pressure is.
Diagnosing open-angle glaucoma
Goldmann applanation tonometry can be used to check the intraocular pressure.
Fundoscopy assessment to check for optic disc cupping and optic nerve health.
Visual field assessment to check for peripheral vision loss.
Managing open-angle glaucoma
Management of glaucoma aims to reduce the intraocular pressure. Treatment is usually started at an intraocular pressure of 24 mmHg or above. Patients are followed up closely to assess the response to treatment.
Prostaglandin analogue eye drops (e.g. latanoprost) are first line. These increase uveoscleral outflow. Notable side effects are eyelash growth, eyelid pigmentation and iris pigmentation (browning).
Other options:
Beta-blockers (e.g. timolol) reduce the production of aqueous humour
Carbonic anhydrase inhibitors (e.g. dorzolamide) reduce the production of aqueous humour
Sympathomimetics (e.g. brimonidine) reduce the production of aqueous fluid and increase uveoscleral outflow
Trabeculectomy surgery may be required where eye drops are ineffective. This involves creating a new channel from the anterior chamber, through the sclera to a location under the conjunctiva. It causes a “bleb” under the conjunctiva where the aqueous humour drains. It is then reabsorbed from this bleb into the general circulation.
Acute angle-closure glaucoma
Glaucoma refers to the optic nerve damage that is caused by a significant rise in intraocular pressure. The raised intraocular pressure is caused by a blockage in aqueous humour trying to escape the eye.
Acute angle-closure glaucoma occurs when the iris bulges forward and seals off the trabecular meshwork from the anterior chamber preventing aqueous humour from being able to drain away. This leads to a continual build-up of pressure in the eye. The pressure builds up particularly in the posterior chamber, which causes pressure behind the iris and worsens the closure of the angle.
Acute angle-closure glaucoma is an ophthalmology emergency. Emergency treatment is required to prevent permanent loss of vision.
Risk factors for acute angle-closure glaucoma
The risk factors are slightly different to open-angle glaucoma:
Increasing age
Females are affected around 4 times more often than males
Family history
Chinese and East Asian ethnic origin. Unlike open-angle glaucoma, it is rare in people of black ethnic origin.
Shallow anterior chamber
Certain medications can precipitate acute angle-closure glaucoma:
Adrenergic medications such as noradrenalin
Anticholinergic medications such as oxybutynin and solifenacin
Tricyclic antidepressants such as amitriptyline, which have anticholinergic effects
Presentation of acute angle-closure glaucoma
The patient will generally appear unwell in themselves. They have a short history of:
Severely painful red eye
Blurred vision
Halos around lights
Associated headache, nausea and vomiting
Examination of acute angle-closure glaucoma
Red-eye
Teary
Hazy cornea
Decreased visual acuity
Dilatation of the affected pupil
Fixed pupil size
Firm eyeball on palpation
Initial management of acute angle-closure glaucoma
NICE CKS 2019 say patients with potentially life-threatening causes of red eye should be referred for same-day assessment by an ophthalmologist. If there is a delay in admission, whilst waiting for an ambulance:
Lie patient on their back without a pillow
Give pilocarpine eye drops (2% for blue, 4% for brown eyes)
Give acetazolamide 500 mg orally
Given analgesia and an antiemetic if required
Pilocarpine acts on the muscarinic receptors in the sphincter muscles in the iris and causes constriction of the pupil. Therefore it is a miotic agent. It also causes ciliary muscle contraction. These two effects cause the pathway for the flow of aqueous humour from the ciliary body, around the iris and into the trabecular meshwork to open up.
Acetazolamide is a carbonic anhydrase inhibitor. This reduces the production of aqueous humour.
Secondary care management of acute angle-closure glaucoma
Various medical options can be tried to reduce the pressure:
Pilocarpine
Acetazolamide (oral or IV)
Hyperosmotic agents such as glycerol or mannitol increase the osmotic gradient between the blood and the fluid in the eye
Timolol is a beta-blocker that reduces the production of aqueous humour
Dorzolamide is a carbonic anhydrase inhibitor that reduces the production of aqueous humour
Brimonidine is a sympathomimetic that reduces the production of aqueous fluid and increase uveoscleral outflow
Laser iridotomy is usually required as a definitive treatment. This involves using a laser to make a hole in the iris to allow the aqueous humour to flow from the posterior chamber into the anterior chamber. This relieves pressure that was pushing the iris against the cornea and allows the humour the drain.
Age related macular degeneration
Age-related macular degeneration is a condition where there is degeneration in the macula that cause a progressive deterioration in vision. In the UK it is the most common cause of blindness. A key finding associated with macular degeneration is drusen seen during fundoscopy.
There are two types, wet and dry. 90% of cases are dry and 10% are wet. Wet age-related macular degeneration carries a worse prognosis.
The macula is made of four key layers. At the bottom, there is the choroid layer, which contains blood vessels that provide the blood supply to the macula. Above that is Bruch’s membrane. Above Bruch’s membrane there is the retinal pigment epithelium and above that are the photoreceptors.
Drusen are yellow deposits of proteins and lipids that appear between the retinal pigment epithelium and Bruch’s membrane. Some drusen can be normal. Normal drusen are small (< 63 micrometres) and hard. Larger and greater numbers of drusen can be an early sign of macular degeneration. They are common to both wet and dry AMD.
Other features that are common to wet and dry AMD are:
Atrophy of the retinal pigment epithelium
Degeneration of the photoreceptors
In wet AMD there is the development of new vessels growing from the choroid layer into the retina. These vessels can leak fluid or blood and cause oedema and more rapid loss of vision. A key chemical that stimulates the development of new vessels is vascular endothelial growth factor (VEGF) and this is the target of medications to treat wet AMD.
Risk factors for age related macular degeneration
Age
Smoking
White or Chinese ethnic origin
Family history
Cardiovascular disease
Presentation of age related macular degeneration
There are some key visual changes to remember for spotting AMD in your exams:
Gradual worsening central visual field loss
Reduced visual acuity
Crooked or wavy appearance to straight lines
Wet age-related macular degeneration presents more acutely. It can present with a loss of vision over days and progress to full loss of vision over 2-3 years. It often progresses to bilateral disease.
Examining age related macular degeneration
Reduced acuity using a Snellen chart
Scotoma (a central patch of vision loss)
Amsler grid test can be used to assess the distortion of straight lines
Fundoscopy. Drusen are the key finding.
Slit-lamp biomicroscopic fundus examination by a specialist can be used to diagnose AMD.
Optical coherence tomography is a technique used to gain a cross-sectional view of the layers of the retina. It can be used to diagnose wet AMD.
Fluorescein angiography involves giving a fluorescein contrast and photographing the retina to look in detail at the blood supply to the retina. It is useful to show up any oedema and neovascularisation. It is used second line to diagnose wet AMD if optical coherence tomography does not exclude wet AMD.
Managing dry AMD
There is no specific treatment for dry age-related macular degeneration. Management focuses on lifestyle measure that may slow the progression:
Avoid smoking
Control blood pressure
Vitamin supplementation has some evidence in slowing progression
Managing wet AMD
Anti-VEGF medications are used to treat wet age-related macular degeneration. Vascular endothelial growth factor is involved in the development of new blood vessels in the retina. Medications such as ranibizumab, bevacizumab and pegaptanib block VEGF and slow the development of new vessels. They are injected directly into the vitreous chamber of the eye once a month. They slow and even reverse the progression of the disease. They typically need to be started within 3 months to be beneficial.
Diabetic retinopathy
Diabetic retinopathy is a condition where the blood vessels in the retina are damaged by prolonged exposure to high blood sugar levels (hyperglycaemia) causing a progressive deterioration in the health of the retina.
Pathophysiology of diabetic retinopathy
Hyperglycaemia leads to damage to the retinal small vessels and endothelial cells. Increased vascular permeability leads to leakage from the blood vessels, blot haemorrhages and the formation of hard exudates. Hard exudates are yellow/white deposits of lipids in the retina.
Damage to the blood vessel walls leads to microaneurysms and venous beading. Microaneurysms are where weakness in the wall causes small bulges. Venous beading is where the walls of the veins are no longer straight and parallel and look more like a string of beads or sausages.
Damage to nerve fibres in the retina causes fluffy white patches to form on the retina called cotton wool spots.
Intraretinal microvascular abnormalities (IMRA) is where there are dilated and tortuous capillaries in the retina. These can act as a shunt between the arterial and venous vessels in the retina.
Neovascularisation is when growth factors are released in the retina causing the development of new blood vessels.
Classification of diabetic retinopathy
Diabetic retinopathy can be split into two broad categories: non-proliferative and proliferative depending on whether new blood vessels have developed. Non-proliferative is often called background or pre-proliferative retinopathy as it can develop in to proliferative retinopathy. A condition called diabetic maculopathy also exists separate from non-proliferative and proliferative diabetic retinopathy.
These conditions are classified based on the findings on fundus examination.
Non-proliferative diabetic retinopathy
Mild: microaneurysms
Moderate: microaneurysms, blot haemorhages, hard exudates, cotton wool spots and venous beading
Severe: blot haemorrhages plus microaneurysms in 4 quadrants, venous beading in 2 quadrates, intraretinal microvascular abnormality (IMRA) in any quadrant